Precision medicine

David Rimm continues the conversation about the best assay for atezolizumab after a recent response to his original article

How valuable can it be to receive fully automated NGS results in a single day? A group of experts share their views

Next-generation sequencing is changing the future of precision oncology with its ability to test for NTRK gene fusions and more

AI diagnostics offer great potential for the future – and as a disease of many challenges, prostate cancer is a great first target

Remote self-sampling may improve diagnosis and prognosis while reducing costs, but numerous factors must be considered for appropriate implementation

In-depth analysis of next-generation sequencing can help personalize cancer treatment and drive the adoption of precision medicine

In today’s increasingly connected society, how can digital pathology facilitate long-distance diagnosis and ease resource pressures across the globe?

An analysis of 1,000 Swedish genomes reveals greater heterogeneity and shows why the human reference genome needs updating

Pharmacogenomic testing can only improve patient care if it’s clinically validated, judiciously applied, and easily understood by healthcare providers

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer